Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioGin is a biotechnology company specializing in the research, development, and production of high-purity active ingredients for the global nutrition, health, and pharmaceutical industries. The company leverages a proprietary synthetic biology platform to manufacture key compounds such as Pyrroloquinoline Quinone (PQQ) and Nicotinamide Mononucleotide (NMN). BioGin focuses on mitochondrial health and cellular energy, providing innovative solutions for aging-related conditions and metabolic wellness. Their products are used in dietary supplements, functional foods, and pharmaceutical applications worldwide. The company maintains a strong focus on R&D and quality control, ensuring their ingredients meet international standards for safety and efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioGin.